These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 3543156

  • 1. Type III group B Streptococcus: functional interaction with IgG subclass antibodies.
    Givner LB, Baker CJ, Edwards MS.
    J Infect Dis; 1987 Mar; 155(3):532-9. PubMed ID: 3543156
    [Abstract] [Full Text] [Related]

  • 2. Functional activity of class-specific antibodies to type III, group B streptococcus.
    Campbell JR, Baker CJ, Metzger TG, Edwards MS.
    Pediatr Res; 1988 Jan; 23(1):31-4. PubMed ID: 3277150
    [Abstract] [Full Text] [Related]

  • 3. A polyclonal human IgG preparation hyperimmune for type III, group B Streptococcus: in vitro opsonophagocytic activity and efficacy in experimental models.
    Givner LB, Edwards MS, Baker CJ.
    J Infect Dis; 1988 Oct; 158(4):724-30. PubMed ID: 3049837
    [Abstract] [Full Text] [Related]

  • 4. Immune globulin for intravenous use: enhancement of in vitro opsonophagocytic activity of neonatal serum.
    Givner LB, Edwards MS, Anderson DC, Baker CJ.
    J Infect Dis; 1985 Feb; 151(2):217-20. PubMed ID: 3918123
    [Abstract] [Full Text] [Related]

  • 5. Pooled human IgG hyperimmune for type III group B streptococci: evaluation against multiple strains in vitro and in experimental disease.
    Givner LB, Baker CJ.
    J Infect Dis; 1991 May; 163(5):1141-5. PubMed ID: 2019763
    [Abstract] [Full Text] [Related]

  • 6. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P, Nicholson-Weller A, Wessels MR.
    J Immunol; 1999 Sep 01; 163(5):2761-8. PubMed ID: 10453019
    [Abstract] [Full Text] [Related]

  • 7. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.
    Fujieda M, Aoyagi Y, Matsubara K, Takeuchi Y, Fujimaki W, Matsushita M, Bohnsack JF, Takahashi S.
    Infect Immun; 2012 Jun 01; 80(6):2053-60. PubMed ID: 22451515
    [Abstract] [Full Text] [Related]

  • 8. Functional activities of various preparations of human intravenous immunoglobulin against type III group B Streptococcus.
    Kim KS, Wass CA, Kang JH, Anthony BF.
    J Infect Dis; 1986 Jun 01; 153(6):1092-7. PubMed ID: 3517187
    [Abstract] [Full Text] [Related]

  • 9. Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci.
    Aoyagi Y, Adderson EE, Min JG, Matsushita M, Fujita T, Takahashi S, Okuwaki Y, Bohnsack JF.
    J Immunol; 2005 Jan 01; 174(1):418-25. PubMed ID: 15611266
    [Abstract] [Full Text] [Related]

  • 10. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
    Lagergård T, Thiringer K, Wassén L, Schneerson R, Trollfors B.
    Eur J Pediatr; 1992 Feb 01; 151(2):98-102. PubMed ID: 1537371
    [Abstract] [Full Text] [Related]

  • 11. Lectin site interaction with capsular polysaccharide mediates nonimmune phagocytosis of type III group B streptococci.
    Albanyan EA, Edwards MS.
    Infect Immun; 2000 Oct 01; 68(10):5794-802. PubMed ID: 10992487
    [Abstract] [Full Text] [Related]

  • 12. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.
    Guttormsen HK, Baker CJ, Nahm MH, Paoletti LC, Zughaier SM, Edwards MS, Kasper DL.
    Infect Immun; 2002 Apr 01; 70(4):1724-38. PubMed ID: 11895934
    [Abstract] [Full Text] [Related]

  • 13. Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine.
    Kasper DL, Paoletti LC, Wessels MR, Guttormsen HK, Carey VJ, Jennings HJ, Baker CJ.
    J Clin Invest; 1996 Nov 15; 98(10):2308-14. PubMed ID: 8941648
    [Abstract] [Full Text] [Related]

  • 14. The opsonic antibody response of female rats to type III group B streptococcal immunization: a model for maternal immunity.
    Heiman HS, Weisman LE.
    Vet Immunol Immunopathol; 1990 Jan 15; 24(1):79-89. PubMed ID: 2180204
    [Abstract] [Full Text] [Related]

  • 15. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
    Givner LB.
    Pediatrics; 1990 Dec 15; 86(6):955-62. PubMed ID: 2123536
    [Abstract] [Full Text] [Related]

  • 16. Opsonophagocytic and bactericidal activity mediated by purified IgG subclass antibodies after vaccination with the Norwegian group B meningococcal vaccine.
    Aase A, Høiby EA, Michaelsen TE.
    Scand J Immunol; 1998 Apr 15; 47(4):388-96. PubMed ID: 9600322
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
    Shyur SD, Raff HV, Bohnsack JF, Kelsey DK, Hill HR.
    J Immunol; 1992 Mar 15; 148(6):1879-84. PubMed ID: 1541826
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-Hinge Antibodies Recognize IgG Subclass- and Protease-Restricted Neoepitopes.
    Falkenburg WJ, van Schaardenburg D, Ooijevaar-de Heer P, Tsang-A-Sjoe MW, Bultink IE, Voskuyl AE, Bentlage AE, Vidarsson G, Wolbink G, Rispens T.
    J Immunol; 2017 Jan 01; 198(1):82-93. PubMed ID: 27864476
    [Abstract] [Full Text] [Related]

  • 20. Intrapulmonary bacterial clearance of type III group B streptococcus is reduced in preterm compared with term rabbits and occurs independent of antibody.
    Hall SL, Sherman MP.
    Am Rev Respir Dis; 1992 May 01; 145(5):1172-7. PubMed ID: 1586063
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.